https://qlinea.com/ 2026-02-09T15:54:37+00:00 https://qlinea.com/annual-general-meeting-2026/ 2026-06-03T13:41:49+00:00 https://qlinea.com/cybersecurity/ 2025-10-21T07:15:47+00:00 https://qlinea.com/extraordinary-general-meeting-2025-2/ 2025-10-09T06:32:48+00:00 https://qlinea.com/investerare/foretradesemission-2024/ 2025-09-19T10:49:18+00:00 https://qlinea.com/investor-relations/corporate-governance/rights-issue-2024/about-the-rights-issue/ 2025-09-19T11:29:38+00:00 https://qlinea.com/investor-relations/corporate-governance/rights-issue-2024/ 2025-09-23T13:00:22+00:00 https://qlinea.com/podler/ 2026-06-10T10:12:45+00:00 https://qlinea.com/annual-general-meeting-2025/ 2025-05-23T12:27:24+00:00 https://qlinea.com/arsstamma-2025/ 2025-06-25T13:39:03+00:00 https://qlinea.com/extra-bolagsstamma-2025/ 2025-03-03T18:10:50+00:00 https://qlinea.com/extraordinary-general-meeting-2025/ 2026-02-12T11:02:30+00:00 https://qlinea.com/investor-relations/rights-issue-2025/ 2025-09-23T13:02:12+00:00 https://qlinea.com/investor-relations/rights-issue-2025/press-releases-about-the-rights-issue/ 2025-09-23T06:54:22+00:00 https://qlinea.com/investor-relations/rights-issue-2025/about-the-rights-issue/ 2025-09-19T11:32:20+00:00 https://qlinea.com/extra-bolagsstamma-2024/ 2024-11-08T09:43:42+00:00 https://qlinea.com/extraordinary-annual-general-meeting-2024/ 2025-06-09T06:46:45+00:00 https://qlinea.com/astar-in-the-clinic/ 2025-02-01T15:19:47+00:00 https://qlinea.com/why-astar/astar-kit/ 2026-04-17T12:48:13+00:00 https://qlinea.com/antimicrobial-resistance/ 2024-07-08T13:02:59+00:00 https://qlinea.com/sepsis/ 2024-07-08T13:04:14+00:00 https://qlinea.com/home-2/ 2025-03-26T06:11:18+00:00 https://qlinea.com/astar-in-the-lab/ 2025-03-21T14:49:23+00:00 https://qlinea.com/about-us/ 2024-05-30T10:35:06+00:00 https://qlinea.com/lifetimes-study-patient-data-use/ 2026-06-10T07:42:04+00:00 https://qlinea.com/annual-general-meeting-2024/ 2024-05-16T14:47:52+00:00 https://qlinea.com/contact-and-media/whistleblowing/ 2024-07-08T13:24:02+00:00 https://qlinea.com/about-us/words-about-us/presentation-stephen-p-kidd/ 2023-10-10T11:34:59+00:00 https://qlinea.com/important-information/ 2023-07-06T07:58:09+00:00 https://qlinea.com/extraordinary-general-meeting-2023/ 2023-06-05T15:54:10+00:00 https://qlinea.com/annual-general-meeting-2023/ 2023-04-21T12:44:32+00:00 https://qlinea.com/distributor-portal/ 2023-03-27T06:35:40+00:00 https://qlinea.com/distributors/ 2026-05-29T09:41:01+00:00 https://qlinea.com/annual-general-meeting-2022/ 2022-04-26T05:36:46+00:00 https://qlinea.com/code-of-conduct/ 2022-06-17T08:52:06+00:00 https://qlinea.com/customer-portal/settings/ 2021-11-12T12:39:26+00:00 https://qlinea.com/login/ 2023-11-17T13:16:32+00:00 https://qlinea.com/customer-portal/ 2024-07-03T12:08:22+00:00 https://qlinea.com/annual-general-meeting-2021/ 2021-04-26T16:14:46+00:00 https://qlinea.com/third-party-licenses/ 2025-08-18T11:24:56+00:00 https://qlinea.com/d41d7c41a238cd674bb30ea96a818f14/ 2021-07-05T06:31:50+00:00 https://qlinea.com/request-product-documents/ 2021-04-26T14:08:05+00:00 https://qlinea.com/request-consultation/ 2021-03-29T06:08:00+00:00 https://qlinea.com/innovation/ 2022-06-16T07:51:44+00:00 https://qlinea.com/support-zone/ 2025-01-28T08:06:10+00:00 https://qlinea.com/webinar-11-10/ 2020-11-11T10:14:07+00:00 https://qlinea.com/webinar-10-11-2020/ 2022-10-20T13:21:07+00:00 https://qlinea.com/patents/ 2024-09-18T13:56:42+00:00 https://qlinea.com/webinar-archive/ 2020-11-11T10:24:00+00:00 https://qlinea.com/investor-relations/press-releases/ 2020-06-18T08:02:36+00:00 https://qlinea.com/contact-and-media/locations-and-directions/ 2026-06-10T07:43:44+00:00 https://qlinea.com/investor-relations/financial-calendar/ 2026-06-22T12:23:16+00:00 https://qlinea.com/examples/ 2020-05-19T06:54:05+00:00 https://qlinea.com/webinar-03-06-2020/ 2022-10-20T13:21:07+00:00 https://qlinea.com/annual-general-meeting-2020/ 2020-04-24T08:11:55+00:00 https://qlinea.com/webinar-registration/ 2020-11-09T09:22:21+00:00 https://qlinea.com/q-linea-intends-to-list-its-shares-on-nasdaq-stockholm/ 2020-01-17T13:48:15+00:00 https://qlinea.com/stabilization-notice-and-end-of-the-stabilization-period/ 2020-01-17T13:48:55+00:00 https://qlinea.com/stabilization-notice/ 2020-01-17T13:49:34+00:00 https://qlinea.com/trading-in-q-lineas-share-commences-tomorrow-on-nasdaq-stockholm/ 2020-01-17T13:49:04+00:00 https://qlinea.com/q-linea-publishes-prospectus-for-initial-public-offering-on-nasdaq/ 2020-01-17T13:49:11+00:00 https://qlinea.com/extraordinary-general-meeting-2018/ 2020-01-15T10:20:22+00:00 https://qlinea.com/annual-general-meeting-2019/ 2020-01-15T12:02:39+00:00 https://qlinea.com/about-us/ceo-comment/ 2026-06-11T13:36:40+00:00 https://qlinea.com/privacy-policy/ 2024-03-18T07:40:40+00:00 https://qlinea.com/contact-and-media/contact/ 2019-12-19T10:50:22+00:00 https://qlinea.com/investor-relations/the-share/share-capital-development/ 2019-12-19T10:49:46+00:00 https://qlinea.com/mission-vision/ 2023-04-11T09:31:07+00:00 https://qlinea.com/why-astar/astar-kits/ 2024-02-19T08:13:35+00:00 https://qlinea.com/why-astar/astar/ 2019-12-19T10:43:51+00:00 https://qlinea.com/investor-relations/ipo/contacts/ 2022-04-06T12:09:49+00:00 https://qlinea.com/investor-relations/ipo/key-dates/ 2020-01-20T17:21:20+00:00 https://qlinea.com/investor-relations/ipo/prospectus/ 2020-01-21T12:35:05+00:00 https://qlinea.com/investor-relations/ipo/press-releases-about-ipo/ 2020-10-12T10:29:54+00:00 https://qlinea.com/investor-relations/ipo/about-the-ipo/ 2020-01-21T11:00:46+00:00 https://qlinea.com/investor-relations/corporate-governance/articles-of-association/ 2025-08-11T07:54:35+00:00 https://qlinea.com/investor-relations/corporate-governance/audit/ 2026-06-02T06:34:15+00:00 https://qlinea.com/investor-relations/corporate-governance/internal-audit-and-control/ 2020-01-20T15:02:08+00:00 https://qlinea.com/investor-relations/corporate-governance/management/renumeration-to-president-and-management-team/ 2026-01-08T08:02:25+00:00 https://qlinea.com/investor-relations/corporate-governance/management/ 2026-06-26T07:20:59+00:00 https://qlinea.com/investor-relations/corporate-governance/board-of-directors/board-committees/ 2026-06-02T06:35:46+00:00 https://qlinea.com/investor-relations/corporate-governance/board-of-directors/board-procedures/ 2020-01-20T15:43:20+00:00 https://qlinea.com/investor-relations/corporate-governance/board-of-directors/remuneration-to-the-board-of-directors/ 2026-06-02T06:39:29+00:00 https://qlinea.com/investor-relations/corporate-governance/board-of-directors/the-boards-duties/ 2026-06-02T06:42:43+00:00 https://qlinea.com/investor-relations/corporate-governance/board-of-directors/ 2026-06-26T07:27:35+00:00 https://qlinea.com/investor-relations/corporate-governance/nomination-committee/ 2026-06-02T07:07:23+00:00 https://qlinea.com/investor-relations/corporate-governance/general-meeting/general-meetings/ 2026-06-18T11:44:23+00:00 https://qlinea.com/investor-relations/corporate-governance/general-meeting/ 2020-01-20T15:01:18+00:00 https://qlinea.com/investor-relations/the-share/ownership-structure/ 2020-11-02T11:08:58+00:00 https://qlinea.com/investor-relations/the-share/trading-information/ 2026-06-10T07:44:24+00:00 https://qlinea.com/contact-and-media/subscribe/ 2019-12-19T07:08:45+00:00 https://qlinea.com/investor-relations/ipo/ 2026-06-22T12:32:08+00:00 https://qlinea.com/investor-relations/corporate-governance/ 2020-01-20T15:13:46+00:00 https://qlinea.com/investor-relations/reports-and-presentations/ 2026-05-22T10:21:08+00:00 https://qlinea.com/investor-relations/the-share/ 2026-06-18T11:13:39+00:00 https://qlinea.com/about-us/resources/ 2026-06-29T06:52:01+00:00 https://qlinea.com/about-us/business-concept-and-strategy/ 2025-03-19T08:09:06+00:00 https://qlinea.com/about-us/news-and-events/ 2025-01-10T10:53:42+00:00 https://qlinea.com/about-us/words-about-us/ 2025-01-10T11:24:49+00:00 https://qlinea.com/research/ 2019-12-04T13:58:50+00:00 https://qlinea.com/why-astar/astar/astar-instrument/ 2020-12-04T08:40:11+00:00 https://qlinea.com/contact-and-media/ 2026-06-26T07:25:44+00:00 https://qlinea.com/investor-relations/ 2026-06-26T07:23:28+00:00 https://qlinea.com/mfn_news/annika-blondeau-henriksson-new-interim-cfo/ 2026-05-29T11:25:27+00:00 https://qlinea.com/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ-8/ 2026-05-28T08:11:07+00:00 https://qlinea.com/mfn_news/interim-report-january-march-2026/ 2026-05-06T06:27:30+00:00 https://qlinea.com/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-8/ 2026-04-28T08:19:08+00:00 https://qlinea.com/mfn_news/q-linea-publish-the-annual-report-for-2025/ 2026-04-24T06:48:45+00:00 https://qlinea.com/mfn_news/q-linea-announces-fda-clearance-of-expanded-astar-blood-testing-menu/ 2026-04-22T08:58:53+00:00 https://qlinea.com/mfn_news/q-linea-announces-shipment-of-two-astar-instruments-to-saudi-arabia/ 2026-04-07T07:53:14+00:00 https://qlinea.com/mfn_news/the-nomination-committees-proposals-to-q-lineas-annual-general-meeting-2026/ 2026-03-11T15:57:56+00:00 https://qlinea.com/financialevent/interim-report-q3-6/ 2026-03-04T15:51:52+00:00 https://qlinea.com/financialevent/interim-report-q2-8/ 2026-03-04T15:49:39+00:00 https://qlinea.com/financialevent/annual-general-meeting-2026/ 2026-03-04T15:48:51+00:00 https://qlinea.com/financialevent/interim-report-q1-6/ 2026-03-04T15:48:09+00:00 https://qlinea.com/financialevent/annual-report-2025/ 2026-03-04T15:46:36+00:00 https://qlinea.com/event/nacmid-2026-nashua/ 2026-02-13T15:16:40+00:00 https://qlinea.com/mfn_news/year-end-report-1-january-31-december-2025/ 2026-02-05T13:27:17+00:00 https://qlinea.com/event/amcli-2026-rimini/ 2026-01-30T10:07:30+00:00 https://qlinea.com/event/asm-microbe-2026-washington-d-c/ 2026-06-05T06:09:06+00:00 https://qlinea.com/event/nscmid-2026-copenhagen/ 2026-01-29T13:30:46+00:00 https://qlinea.com/event/whx-labs-2026-dubai/ 2026-01-29T13:16:49+00:00 https://qlinea.com/event/nycasm-2026-new-york-city/ 2026-01-27T15:14:38+00:00 https://qlinea.com/event/swacm-2026-houston/ 2026-01-29T13:09:56+00:00 https://qlinea.com/event/idweek-2026-washington-dc/ 2026-01-23T09:41:12+00:00 https://qlinea.com/event/adlm-2026-anaheim/ 2026-01-22T11:53:52+00:00 https://qlinea.com/event/mad-id-2026-orlando/ 2026-04-22T09:07:18+00:00 https://qlinea.com/event/escmid-global-2026-munich/ 2026-03-11T07:16:46+00:00 https://qlinea.com/mfn_news/large-independent-hospital-in-southeastern-united-states-adopts-astar/ 2026-01-20T07:47:20+00:00 https://qlinea.com/event/ewc-2026-new-orleans/ 2026-01-14T12:52:59+00:00 https://qlinea.com/event/scacm-2026-indianapolis/ 2026-03-31T14:45:08+00:00 https://qlinea.com/mfn_news/q-linea-announces-changes-in-us-commercial-leadership/ 2026-01-07T07:51:06+00:00 https://qlinea.com/mfn_news/q-linea-signs-first-distribution-agreement-in-south-asia/ 2026-01-07T08:03:55+00:00 https://qlinea.com/mfn_news/q-linea-ab-publ-omx-qlinea-today-announces-it-will-provide-astar-to-italian-users-of-the-accelerate-pheno-rapid-ast-system/ 2026-01-07T07:54:59+00:00 https://qlinea.com/mfn_news/q-linea-announces-first-two-us-hospital-systems-clinical-implementation-of-astar/ 2026-01-07T07:52:39+00:00 https://qlinea.com/event/ricai-2025/ 2025-12-17T09:11:19+00:00 https://qlinea.com/mfn_news/new-number-of-shares-and-votes-in-q-linea-ab-publ-5/ 2025-11-28T12:59:41+00:00 https://qlinea.com/mfn_news/q-linea-announces-new-organisation-and-changes-in-executive-leadership-team/ 2025-11-20T15:48:44+00:00 https://qlinea.com/mfn_news/q-linea-announces-fda-submission-for-expanded-claims-for-astar-bc-g-panel/ 2025-11-18T12:07:59+00:00 https://qlinea.com/mfn_news/q-linea-resolves-to-carry-out-a-directed-issue-of-shares-to-a-guarantor-in-connection-with-the-completed-preferential-rights-issue/ 2025-11-18T12:06:57+00:00 https://qlinea.com/mfn_news/q-linea-announces-outcome-of-rights-issue-3/ 2025-11-12T08:00:43+00:00 https://qlinea.com/mfn_news/q-linea-publishes-prospectus-in-connection-with-the-rights-issue-3/ 2025-10-22T14:21:26+00:00 https://qlinea.com/mfn_news/q-linea-announces-cost-efficiency-program-to-accelerate-sales-and-marketing-activities/ 2025-10-22T14:17:32+00:00 https://qlinea.com/mfn_news/bulletin-from-extraordinary-general-meeting-in-q-linea-ab-publ-3/ 2025-10-22T14:13:58+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-september-2025/ 2025-10-20T06:44:01+00:00 https://qlinea.com/mfn_news/stuart-gander-appointed-ceo-and-anders-ljunggren-appointed-deputy-ceo-of-q-linea-ab/ 2025-10-20T06:45:21+00:00 https://qlinea.com/mfn_news/us-trauma-center-signs-commercial-contract/ 2025-10-03T08:08:41+00:00 https://qlinea.com/mfn_news/notice-of-extraordinary-general-meeting-in-q-linea-ab-publ-4/ 2025-09-18T12:45:56+00:00 https://qlinea.com/mfn_news/q-linea-letter-from-the-ceo/ 2025-09-18T12:45:05+00:00 https://qlinea.com/mfn_news/q-linea-resolves-to-carry-out-a-rights-issue-of-approximately-sek-322-million-and-announces-terms/ 2025-09-18T12:41:23+00:00 https://qlinea.com/mfn_news/update-on-estar-tender-for-rapid-ast/ 2025-09-11T06:31:06+00:00 https://qlinea.com/mfn_news/q-linea-to-initiate-new-clinical-evaluations-of-astar-in-the-gcc-region/ 2025-09-05T10:44:09+00:00 https://qlinea.com/financialevent/year-end-report-8/ 2025-08-22T07:18:33+00:00 https://qlinea.com/event/imari-2025/ 2025-11-12T08:36:00+00:00 https://qlinea.com/mfn_news/new-number-of-shares-and-votes-in-q-linea-ab-publ-4/ 2025-08-11T14:33:08+00:00 https://qlinea.com/mfn_news/blastid-and-q-linea-announce-collaboration-and-conference-presentation/ 2025-08-11T14:32:18+00:00 https://qlinea.com/event/eastern-pa-asm/ 2025-09-30T11:59:21+00:00 https://qlinea.com/event/nacmid-2025/ 2025-08-14T07:30:37+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-june-2025/ 2025-07-10T06:46:49+00:00 https://qlinea.com/mfn_news/correction-last-trading-day-before-reverse-share-split/ 2025-07-10T06:44:20+00:00 https://qlinea.com/mfn_news/q-linea-ab-announces-timetable-for-reverse-share-split/ 2025-07-08T12:04:55+00:00 https://qlinea.com/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ-7/ 2025-06-27T06:44:20+00:00 https://qlinea.com/event/swacm-2025/ 2025-08-14T07:30:55+00:00 https://qlinea.com/event/idweek-2025/ 2025-08-19T06:46:40+00:00 https://qlinea.com/event/sidp-annual-meeting-2025/ 2025-08-14T07:30:42+00:00 https://qlinea.com/mfn_news/q-linea-on-track-for-2025-plan/ 2025-06-20T08:23:49+00:00 https://qlinea.com/event/asm-microbe-2025-los-angeles/ 2025-06-23T06:24:10+00:00 https://qlinea.com/mfn_news/new-number-of-shares-and-votes-in-q-linea-ab-publ-3/ 2025-06-02T06:21:32+00:00 https://qlinea.com/mfn_news/q-lineas-board-of-directors-proposes-a-reverse-share-split-and-a-reduction-of-the-share-capital/ 2025-05-27T11:37:26+00:00 https://qlinea.com/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-7/ 2025-05-23T08:31:20+00:00 https://qlinea.com/mfn_news/q-linea-announces-outcome-of-the-exercise-of-warrants-of-series-to1/ 2025-05-21T12:17:22+00:00 https://qlinea.com/mfn_news/today-15-may-2025-is-the-last-day-of-trading-in-warrants-series-to-1-in-q-linea/ 2025-05-15T07:19:59+00:00 https://qlinea.com/mfn_news/the-proposal-by-the-nomination-committee-of-q-linea-ab-publ-for-election-of-members-of-the-board-of-directors-6/ 2025-05-15T07:16:17+00:00 https://qlinea.com/presentations/presentation-redeye-theme-medtech-on-may-8-2025/ 2025-05-09T08:32:01+00:00 https://qlinea.com/event/stuart-gander-ceo-q-linea-presents-at-redeye-theme-medtech/ 2025-06-12T08:03:32+00:00 https://qlinea.com/mfn_news/q-linea-announces-determined-exercise-price-for-warrants-series-to-1-and-update-regarding-subscription-intentions/ 2025-05-02T13:48:50+00:00 https://qlinea.com/mfn_news/q-linea-announces-changes-in-executive-leadership-team-2/ 2025-04-28T14:35:20+00:00 https://qlinea.com/mfn_news/q-linea-publish-the-annual-report-for-2024/ 2025-04-25T17:05:59+00:00 https://qlinea.com/mfn_news/q-linea-announces-strong-support-of-the-to1-warrant-program-as-well-as-an-extension-of-existing-loan-from-large-shareholder/ 2025-04-16T08:23:06+00:00 https://qlinea.com/mfn_news/interim-report-1-january-31-march-2025/ 2025-04-14T06:58:47+00:00 https://qlinea.com/mfn_news/first-astar-evaluation-in-abu-dhabi-united-arab-emirates/ 2025-04-08T12:19:11+00:00 https://qlinea.com/mfn_news/changed-date-for-interim-report-3/ 2025-04-08T11:37:45+00:00 https://qlinea.com/mfn_news/bulletin-from-extraordinary-general-meeting-of-q-linea-ab-publ/ 2025-04-03T15:15:25+00:00 https://qlinea.com/mfn_news/new-number-of-shares-and-votes-in-q-linea-ab-publ-2/ 2025-03-31T14:39:53+00:00 https://qlinea.com/mfn_news/q-linea-announces-the-sale-of-warrants-of-series-to-1-from-nexttobe-ab-to-investment-ab-oresund/ 2025-03-27T10:14:24+00:00 https://qlinea.com/mfn_news/q-linea-announces-tender-win-in-italy/ 2025-03-25T08:40:26+00:00 https://qlinea.com/presentations/biostock-interview-with-mario-gualano/ 2025-03-24T08:02:02+00:00 https://qlinea.com/mfn_news/additional-allocation-of-units-within-the-framework-of-recently-completed-issues/ 2025-03-19T13:46:18+00:00 https://qlinea.com/mfn_news/q-linea-anticipates-accelerating-astar-placements-through-2025-and-2026-driving-revenue-growth/ 2025-03-18T09:40:20+00:00 https://qlinea.com/mfn_news/master-service-agreement-signed-with-large-us-reference-laboratory/ 2025-03-10T08:33:19+00:00 https://qlinea.com/mfn_news/q-linea-announces-the-initiation-of-another-us-astar-evaluation/ 2025-03-07T10:23:11+00:00 https://qlinea.com/financialevent/extraordinary-general-meeting-in-q-linea-ab-publ/ 2025-03-05T09:12:58+00:00 https://qlinea.com/mfn_news/notice-of-extraordinary-general-meeting-in-q-linea-ab-publ-3/ 2025-03-03T13:47:07+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-year-end-report-q4-2024-on-february-28-2025/ 2025-03-03T14:49:56+00:00 https://qlinea.com/mfn_news/new-number-of-shares-and-votes-in-q-linea-ab-publ/ 2025-03-03T15:06:30+00:00 https://qlinea.com/mfn_news/year-end-report-1-january-31-december-2024/ 2025-03-03T15:03:59+00:00 https://qlinea.com/mfn_news/q-linea-receives-contract-for-second-us-astar-instrument/ 2025-02-25T14:57:35+00:00 https://qlinea.com/mfn_news/q-lineas-rights-issue-is-registered-conversion-of-btu-into-shares-and-warrants/ 2025-02-13T14:20:38+00:00 https://qlinea.com/event/ammi-canada-cacmid/ 2025-06-12T08:03:48+00:00 https://qlinea.com/mfn_news/q-linea-shares-progress-on-roll-out-in-the-middle-east/ 2025-02-11T10:08:45+00:00 https://qlinea.com/mfn_news/q-linea-resolves-to-carry-out-a-directed-issue-of-units-to-guarantors-in-connection-with-the-completed-preferential-rights-issue/ 2025-02-10T16:12:07+00:00 https://qlinea.com/mfn_news/q-linea-awarded-first-public-tender-in-belgium/ 2025-02-05T09:25:11+00:00 https://qlinea.com/mfn_news/ghent-university-publishes-astar-study-results/ 2025-02-04T20:27:30+00:00 https://qlinea.com/mfn_news/q-linea-announces-outcome-of-rights-issue-2/ 2025-02-03T14:36:22+00:00 https://qlinea.com/mfn_news/vikas-gupta-pharmd-fidsa-joins-q-linea-as-senior-director-of-clinical-affairs/ 2025-01-31T12:56:07+00:00 https://qlinea.com/mfn_news/q-linea-announces-preliminary-outcome-of-the-rights-issue/ 2025-01-31T11:56:15+00:00 https://qlinea.com/mfn_news/q-linea-publishes-supplementary-prospectus-in-connection-with-rights-issue/ 2025-01-31T11:57:45+00:00 https://qlinea.com/mfn_news/continued-commercial-progress-with-us-reference-laboratory/ 2025-01-31T11:58:35+00:00 https://qlinea.com/event/adlm-2025-chicago/ 2025-08-11T14:37:51+00:00 https://qlinea.com/event/scacm-2025-spring-meeting/ 2025-06-12T08:04:12+00:00 https://qlinea.com/event/escmid-global/ 2025-06-11T14:42:52+00:00 https://qlinea.com/event/52-congresso-nazionale-amcli/ 2025-06-12T08:04:24+00:00 https://qlinea.com/mfn_news/first-us-customer-signs-commercial-contract/ 2025-01-14T08:06:54+00:00 https://qlinea.com/mfn_news/q-linea-publishes-prospectus-in-connection-with-the-rights-issue-2/ 2025-01-14T15:07:23+00:00 https://qlinea.com/mfn_news/q-linea-resolves-on-the-terms-for-a-rights-issue-of-approximately-sek-225-million/ 2025-01-07T08:04:55+00:00 https://qlinea.com/mfn_news/bulletin-from-extraordinary-general-meeting-in-q-linea-ab-publ-2/ 2024-12-09T08:06:45+00:00 https://qlinea.com/mfn_news/notice-of-extraordinary-general-meeting-in-q-linea-ab-publ-2/ 2024-11-07T15:37:28+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-september-2024/ 2024-11-05T07:18:25+00:00 https://qlinea.com/mfn_news/q-linea-resolves-to-carry-out-a-rights-issue-of-approximately-sek-225-million-and-enters-into-an-agreement-for-a-bridge-loan-facility-of-approximately-sek-40-million/ 2024-11-05T07:26:13+00:00 https://qlinea.com/mfn_news/q-linea-to-participate-in-a-multi-site-public-tender-in-italy/ 2024-10-30T09:11:54+00:00 https://qlinea.com/mfn_news/astar-evaluation-begins-at-a-us-national-cancer-institute-designated-cancer-center/ 2024-10-29T08:33:07+00:00 https://qlinea.com/mfn_news/changed-date-for-interim-report-2/ 2024-10-29T08:37:02+00:00 https://qlinea.com/mfn_news/q-linea-receives-request-for-a-3-year-contract-at-prominent-hospital-in-milan-italy/ 2024-10-25T10:28:42+00:00 https://qlinea.com/mfn_news/two-uk-commercial-evaluations-closing-successfully/ 2024-10-24T13:46:34+00:00 https://qlinea.com/mfn_news/q-linea-announces-the-initiation-of-a-door-mat-study-at-a-large-us-academic-medical-center/ 2024-10-24T10:12:57+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q3-2024-on-october-31-2024/ 2024-10-24T10:19:13+00:00 https://qlinea.com/mfn_news/us-reference-laboratory-completes-astar-evaluation/ 2024-10-21T07:16:33+00:00 https://qlinea.com/mfn_news/q-linea-further-expands-us-commercial-team/ 2024-10-08T07:02:45+00:00 https://qlinea.com/mfn_news/q-linea-announces-changes-in-executive-leadership-team/ 2024-10-08T07:09:55+00:00 https://qlinea.com/mfn_news/q-linea-enters-the-middle-east-region-through-partnership-with-amico-group/ 2024-09-27T10:52:31+00:00 https://qlinea.com/presentations/recorded-webinar-clinical-evaluation-of-an-fda-cleared-high-throughput-rapid-antibiotic-susceptibility-testing-system/ 2024-10-29T08:52:15+00:00 https://qlinea.com/mfn_news/two-leading-us-microbiology-labs-present-interim-evaluation-data-on-webinar/ 2024-09-26T15:37:00+00:00 https://qlinea.com/event/scacm-fall-meeting-michigan/ 2025-01-22T07:18:53+00:00 https://qlinea.com/event/nacmid-2024-conference/ 2025-01-22T07:19:52+00:00 https://qlinea.com/mfn_news/q-linea-enters-into-distribution-agreement-with-s-c-mecro-system-s-r-l/ 2024-09-11T06:55:18+00:00 https://qlinea.com/mfn_news/cms-grants-new-technology-add-on-payment-ntap-for-astar/ 2024-08-28T14:39:17+00:00 https://qlinea.com/mfn_news/astar-evaluation-data-presented-at-swacm-by-leading-us-health-system-medical-center/ 2024-08-28T07:30:11+00:00 https://qlinea.com/event/webinar-clinical-evaluation-of-an-fda-cleared-high-throughput-rapid-antibiotic-susceptibility-testing-system/ 2025-01-22T07:21:00+00:00 https://qlinea.com/event/swacm-2024-annual-meeting/ 2025-01-22T07:21:20+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-june-2024/ 2024-07-11T06:23:08+00:00 https://qlinea.com/financialevent/interim-report-q3-5/ 2025-08-22T07:00:27+00:00 https://qlinea.com/financialevent/interim-report-q2-7/ 2024-07-09T11:38:05+00:00 https://qlinea.com/financialevent/annual-general-meeting-2025/ 2025-02-18T14:28:43+00:00 https://qlinea.com/financialevent/interim-report-q1-5/ 2025-04-08T06:34:23+00:00 https://qlinea.com/financialevent/annual-report-2024/ 2025-03-10T11:39:01+00:00 https://qlinea.com/financialevent/year-end-report-7/ 2025-01-20T08:09:31+00:00 https://qlinea.com/presentations/q-linea-q1-report-2024/ 2024-07-09T11:41:48+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q2-2024-on-july-11-2024/ 2024-10-29T11:44:21+00:00 https://qlinea.com/mfn_news/q-linea-participates-in-first-public-tender-in-belgium/ 2024-07-02T09:27:29+00:00 https://qlinea.com/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ-6/ 2024-07-02T09:46:16+00:00 https://qlinea.com/mfn_news/q-linea-announces-shipment-of-first-ivd-marked-astar-instrument-to-the-us/ 2024-06-28T13:29:14+00:00 https://qlinea.com/event/idweek-2024/ 2025-01-22T07:21:40+00:00 https://qlinea.com/event/adlm-2024/ 2025-01-22T07:21:55+00:00 https://qlinea.com/mfn_news/q-linea-receives-another-commercial-order-in-italy/ 2024-06-19T12:01:48+00:00 https://qlinea.com/mfn_news/cms-proposes-to-approve-the-astar-system-for-ntap-funding/ 2024-06-11T17:48:42+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q1-2024-on-may-31-2024/ 2024-05-31T11:04:18+00:00 https://qlinea.com/mfn_news/interim-report-1-january-31-march-2024/ 2024-05-31T11:04:49+00:00 https://qlinea.com/mfn_news/extended-loan-facility-from-main-shareholder-nexttobe-clarification/ 2024-05-30T10:29:13+00:00 https://qlinea.com/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-6/ 2024-05-29T13:03:26+00:00 https://qlinea.com/mfn_news/q-linea-is-offered-an-extended-loan-facility-by-the-main-shareholder-nexttobe/ 2024-05-29T11:20:33+00:00 https://qlinea.com/mfn_news/technology-behind-podler-valued-at-sek-70-million/ 2024-05-28T07:20:43+00:00 https://qlinea.com/mfn_news/changed-date-for-interim-report/ 2024-05-27T10:24:02+00:00 https://qlinea.com/mfn_news/changed-dates-for-interim-report-and-annual-general-meeting/ 2024-05-15T09:47:50+00:00 https://qlinea.com/mfn_news/q-linea-applies-for-a-ntap-code-for-the-us-market/ 2024-05-03T06:48:30+00:00 https://qlinea.com/mfn_news/q-linea-signs-evaluation-contract-with-reference-laboratory-network-in-the-us/ 2024-05-02T09:05:54+00:00 https://qlinea.com/mfn_news/q-linea-receives-us-fda-510k-clearance-for-the-astar-system/ 2024-04-26T13:42:06+00:00 https://qlinea.com/presentations/life-science-day-2024/ 2025-05-09T08:13:46+00:00 https://qlinea.com/mfn_news/q-linea-publish-the-annual-report-for-2023/ 2024-04-12T06:01:50+00:00 https://qlinea.com/presentations/redeye-theme-commercialization-in-life-science-on-march-20-2024/ 2024-03-21T12:56:38+00:00 https://qlinea.com/presentations/carnegie-healthcare-seminar-2024-mars-6/ 2024-03-18T13:48:26+00:00 https://qlinea.com/mfn_news/strong-astar-results-presented-at-amcli/ 2024-03-13T12:46:41+00:00 https://qlinea.com/mfn_news/q-linea-participates-in-tender-for-rapid-ast/ 2024-03-05T09:00:58+00:00 https://qlinea.com/mfn_news/year-end-report-1-january-31-december-2023/ 2024-02-27T06:38:53+00:00 https://qlinea.com/mfn_news/q-linea-presents-at-amcli/ 2024-02-15T13:32:57+00:00 https://qlinea.com/mfn_news/q-linea-creates-separate-subsidiary-for-podler/ 2024-02-09T07:33:33+00:00 https://qlinea.com/mfn_news/q-linea-signs-agreement-with-logistics-partner-for-the-american-market/ 2024-02-08T13:31:33+00:00 https://qlinea.com/mfn_news/anders-ljunggren-takes-office-as-managing-director-of-q-linea-ab-on-1-march-2024/ 2024-02-01T09:30:58+00:00 https://qlinea.com/mfn_news/labema-oy-places-its-first-astar-order/ 2024-02-01T09:31:09+00:00 https://qlinea.com/mfn_news/q-linea-initiates-cost-savings-program/ 2024-01-30T09:03:39+00:00 https://qlinea.com/mfn_news/stuart-gander-takes-over-as-ceo-of-q-linea-on-march-1-2024/ 2024-01-22T14:29:44+00:00 https://qlinea.com/mfn_news/q-linea-expands-the-gram-negative-panel/ 2024-01-17T12:04:09+00:00 https://qlinea.com/mfn_news/q-linea-wins-public-tender-for-rapid-ast/ 2024-01-15T15:09:58+00:00 https://qlinea.com/mfn_news/changed-date-for-year-end-report/ 2024-01-15T15:10:24+00:00 https://qlinea.com/mfn_news/q-linea-installs-first-astars-in-the-united-states-pending-market-approval/ 2023-12-28T10:54:13+00:00 https://qlinea.com/mfn_news/q-linea-signs-distribution-partnership-for-benelux/ 2023-11-17T09:05:25+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-september-2023/ 2023-11-02T07:18:10+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q3-2023-on-november-2-2023/ 2023-11-01T11:57:10+00:00 https://qlinea.com/mfn_news/q-linea-strengthens-its-presence-in-finland-and-the-baltics-through-partnership-with-labema-oy/ 2023-10-19T06:59:55+00:00 https://qlinea.com/testimonials/the-astar-system-represents-an-exciting-innovative-platform/ 2023-10-10T11:49:52+00:00 https://qlinea.com/mfn_news/strong-astar-results-presented-at-ibms/ 2023-10-02T11:25:29+00:00 https://qlinea.com/mfn_news/q-linea-receives-second-astar-order-in-france/ 2023-09-28T13:02:50+00:00 https://qlinea.com/mfn_news/jonas-jarvius-to-step-down-as-ceo-of-q-linea-during-2024/ 2023-09-07T06:45:25+00:00 https://qlinea.com/event/asm-2024/ 2025-01-22T07:22:13+00:00 https://qlinea.com/event/eccmid-2024/ 2025-01-22T07:22:34+00:00 https://qlinea.com/event/nscmid-2023-2/ 2024-03-18T14:53:29+00:00 https://qlinea.com/event/id-week-2023/ 2024-03-18T14:53:47+00:00 https://qlinea.com/mfn_news/change-in-the-number-of-shares-and-votes-in-q-linea-ab-8/ 2023-08-31T13:03:49+00:00 https://qlinea.com/financialevent/interim-report-q3-4/ 2024-10-28T09:41:06+00:00 https://qlinea.com/financialevent/interim-report-q2-6/ 2023-08-28T12:47:56+00:00 https://qlinea.com/financialevent/annual-general-meeting-2024/ 2024-05-15T12:11:29+00:00 https://qlinea.com/financialevent/interim-report-q1-4/ 2024-05-27T10:24:24+00:00 https://qlinea.com/financialevent/annual-report-2023/ 2023-08-28T12:43:42+00:00 https://qlinea.com/financialevent/year-end-report-6/ 2024-01-15T07:12:54+00:00 https://qlinea.com/mfn_news/change-in-the-number-of-shares-and-votes-in-q-linea-ab-7/ 2023-08-23T11:18:50+00:00 https://qlinea.com/mfn_news/q-linea-receives-first-astar-order-in-france/ 2023-08-23T11:19:22+00:00 https://qlinea.com/mfn_news/q-linea-announces-outcome-of-rights-issue/ 2023-07-26T18:55:45+00:00 https://qlinea.com/mfn_news/q-linea-has-completed-its-us-market-application/ 2023-07-20T18:47:27+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-june-2023/ 2023-07-13T07:54:28+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q2-2023-on-july-13-2023/ 2023-07-20T18:46:27+00:00 https://qlinea.com/mfn_news/q-linea-strengthens-commercial-leadership-team-in-usa/ 2023-07-07T07:19:30+00:00 https://qlinea.com/mfn_news/q-linea-publishes-prospectus-in-connection-with-the-rights-issue/ 2023-07-06T08:31:34+00:00 https://qlinea.com/mfn_news/q-linea-strengthens-commercial-leadership-team-in-europe/ 2023-07-04T13:14:20+00:00 https://qlinea.com/mfn_news/bulletin-from-extraordinary-general-meeting-in-q-linea-ab-publ/ 2023-07-03T13:46:54+00:00 https://qlinea.com/event/presentation-q2-2023-results/ 2023-07-02T13:59:47+00:00 https://qlinea.com/mfn_news/q-linea-uses-an-additional-30-msek-within-the-framework-of-previously-communicated-loan-facility-from-the-main-owner-nexttobe/ 2023-06-21T13:18:01+00:00 https://qlinea.com/mfn_news/q-linea-sponsored-health-economics-study-enrols-first-patient/ 2023-06-15T22:43:57+00:00 https://qlinea.com/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ-5/ 2023-06-13T18:32:07+00:00 https://qlinea.com/mfn_news/q-linea-signs-distribution-partnership-for-france/ 2023-06-13T11:53:43+00:00 https://qlinea.com/financialevent/extra-annual-general-meeting-2023/ 2023-06-08T14:53:54+00:00 https://qlinea.com/presentations/redeye-growth-day-2023-interview-with-ceo-jonas-jarvius/ 2023-06-05T10:03:31+00:00 https://qlinea.com/mfn_news/notice-of-extraordinary-general-meeting-in-q-linea-ab-publ/ 2023-06-02T06:53:43+00:00 https://qlinea.com/mfn_news/q-linea-resolves-on-an-underwritten-rights-issue-of-approximately-sek-263-million/ 2023-06-02T12:40:51+00:00 https://qlinea.com/event/asm-microbe-2023/ 2025-01-22T07:23:04+00:00 https://qlinea.com/mfn_news/q-lineas-partner-pro-lab-diagnostics-starts-its-first-commercial-evaluation-in-the-uk/ 2023-05-23T14:46:46+00:00 https://qlinea.com/mfn_news/q-linea-participates-in-first-italian-public-tender/ 2023-05-23T14:48:45+00:00 https://qlinea.com/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-5/ 2023-05-15T18:43:29+00:00 https://qlinea.com/event/the-infection-week-microbiological-spring-meeting/ 2023-05-15T10:19:28+00:00 https://qlinea.com/event/presentation-readeye-medtech-event-may-10-2023/ 2023-05-11T15:37:35+00:00 https://qlinea.com/mfn_news/q-linea-signs-distribution-agreement-for-norway/ 2023-05-10T09:22:16+00:00 https://qlinea.com/event/presentation-interim-report-january-march-2023/ 2023-05-04T15:47:49+00:00 https://qlinea.com/mfn_news/interim-report-1-january-31-march-2023/ 2023-05-04T06:27:21+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q1-2023-on-may-4-2023/ 2023-04-27T11:33:17+00:00 https://qlinea.com/mfn_news/changed-date-for-the-annual-general-meeting/ 2023-04-24T11:07:58+00:00 https://qlinea.com/mfn_news/q-linea-initiates-cost-saving-program/ 2023-04-24T08:37:18+00:00 https://qlinea.com/mfn_news/q-linea-publish-the-annual-report-for-2022/ 2023-04-13T06:27:57+00:00 https://qlinea.com/event/q-linea-presents-at-life-science-investor-konference-in-copenhagen-new-time/ 2023-04-12T14:39:42+00:00 https://qlinea.com/mfn_news/q-linea-presents-at-life-science-investor-konference-in-copenhagen-new-time/ 2023-04-12T14:22:05+00:00 https://qlinea.com/mfn_news/q-linea-presents-at-life-science-investor-konference-in-copenhagen/ 2023-04-05T07:03:23+00:00 https://qlinea.com/mfn_news/q-linea-signs-distribution-partnership-for-poland/ 2023-04-04T12:18:01+00:00 https://qlinea.com/mfn_news/q-linea-receives-first-astar-orders-under-new-commercialization-strategy/ 2023-04-03T11:09:28+00:00 https://qlinea.com/mfn_news/the-proposal-by-the-nomination-committee-of-q-linea-ab-publ-for-election-of-members-of-the-board-of-directors-5/ 2023-04-03T11:12:38+00:00 https://qlinea.com/mfn_news/q-linea-ab-appoints-abg-sundal-collier-as-liquidity-provider/ 2023-03-30T18:21:45+00:00 https://qlinea.com/mfn_news/q-linea-is-granted-a-short-term-interest-free-loan-from-the-main-owner-nexttobe-within-the-framework-of-the-previously-communicated-loan-facility/ 2023-03-17T13:03:23+00:00 https://qlinea.com/mfn_news/european-astar-clinical-impact-study-receives-ethical-approval/ 2023-03-16T07:18:23+00:00 https://qlinea.com/event/presentation-stockholm-corporate-finance-15th-life-science-capital-market-days/ 2023-03-15T16:12:13+00:00 https://qlinea.com/mfn_news/q-linea-presents-at-stockholm-corporate-finance-15th-life-science-capital-market-days/ 2023-02-28T12:06:11+00:00 https://qlinea.com/event/eccmid-2023/ 2025-06-12T08:05:22+00:00 https://qlinea.com/mfn_news/q-linea-hires-new-cfo/ 2023-02-16T10:02:29+00:00 https://qlinea.com/mfn_news/year-end-report-1-january-31-december-2022/ 2023-02-16T09:16:13+00:00 https://qlinea.com/mfn_news/q-linea-updates-strategy-and-is-offered-updated-loan-facility/ 2023-02-16T09:55:45+00:00 https://qlinea.com/mfn_news/q-linea-prepare-to-start-additional-testing-for-us-510k-application/ 2023-03-14T11:15:50+00:00 https://qlinea.com/mfn_news/q-linea-receives-ivdr-certification/ 2023-02-15T07:21:17+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-year-end-report-q4-2022-on-february-16-2023/ 2023-02-10T12:21:05+00:00 https://qlinea.com/mfn_news/q-linea-signs-uk-distribution-partnership/ 2023-02-08T07:37:25+00:00 https://qlinea.com/mfn_news/q-linea-strengthens-management-team-4/ 2023-01-19T12:33:47+00:00 https://qlinea.com/mfn_news/q-linea-participates-in-comparative-rapid-ast-study/ 2022-12-13T12:25:27+00:00 https://qlinea.com/presentations/redeye-life-science-day-2022-interview-with-ceo-jonas-jarvius/ 2022-12-07T14:01:16+00:00 https://qlinea.com/presentations/trading-direkt-healthcare-interview-november-2022/ 2022-11-10T12:33:51+00:00 https://qlinea.com/event/framtidens-halsa-sjukvard-2023/ 2023-01-13T10:22:47+00:00 https://qlinea.com/mfn_news/q-linea-is-offered-a-loan-facility-of-sek-100-million-from-main-owner-nexttobe/ 2022-11-01T12:05:52+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-september-2022/ 2022-10-31T07:02:29+00:00 https://qlinea.com/mfn_news/q-lineas-q3-interim-report-will-be-published-on-october-31-2022/ 2022-10-31T07:04:22+00:00 https://qlinea.com/mfn_news/q-linea-changes-astar-distribution/ 2022-10-27T06:04:06+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-june-2022/ 2023-12-13T11:00:46+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q2-2022-on-july-14-2022/ 2023-12-13T11:00:46+00:00 https://qlinea.com/mfn_news/q-linea-receives-letter-of-intent-to-evaluate-and-potential-commercialization-of-podler/ 2023-12-13T11:00:46+00:00 https://qlinea.com/mfn_news/q-lineas-publishes-digital-annual-report-for-2021/ 2023-12-13T11:00:46+00:00 https://qlinea.com/mfn_news/q-linea-submits-us-market-application-to-fda/ 2023-12-13T11:00:46+00:00 https://qlinea.com/financialevent/interim-report-q3-3/ 2023-11-01T11:15:15+00:00 https://qlinea.com/financialevent/interim-report-q2-5/ 2023-07-13T13:09:44+00:00 https://qlinea.com/financialevent/annual-general-meeting-2022/ 2023-06-08T14:50:17+00:00 https://qlinea.com/financialevent/interim-report-q1-3/ 2022-06-02T08:35:11+00:00 https://qlinea.com/financialevent/annual-report-2022/ 2022-06-02T08:34:35+00:00 https://qlinea.com/financialevent/year-end-report-5/ 2022-06-02T08:31:45+00:00 https://qlinea.com/mfn_news/q-linea-achieves-ce-mark-conformity-to-ivdr-for-the-astar-instrument/ 2023-12-13T11:00:47+00:00 https://qlinea.com/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ-4/ 2023-12-13T11:00:47+00:00 https://qlinea.com/mfn_news/interim-report-1-january-31-march-2022/ 2023-12-13T11:00:47+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q1-2022-on-may-5-2022/ 2023-12-13T11:00:47+00:00 https://qlinea.com/event/redeye-medtech-diagnostics-seminar-may-11-2022/ 2022-05-13T07:03:21+00:00 https://qlinea.com/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-4/ 2023-12-13T11:00:48+00:00 https://qlinea.com/mfn_news/the-proposal-by-the-nomination-committee-of-q-linea-ab-publ-for-election-of-members-of-the-board-of-directors-4/ 2023-12-13T11:00:48+00:00 https://qlinea.com/mfn_news/q-linea-exhibits-at-eccmid/ 2023-12-13T11:00:48+00:00 https://qlinea.com/mfn_news/q-linea-publish-the-annual-report-for-2021/ 2023-12-13T11:00:49+00:00 https://qlinea.com/mfn_news/q-lineas-astar-classified-as-a-breakthrough-device-by-the-fda/ 2023-12-13T11:00:49+00:00 https://qlinea.com/event/asm-2022/ 2022-10-28T09:12:01+00:00 https://qlinea.com/event/eccmid-2022/ 2022-04-26T11:07:54+00:00 https://qlinea.com/mfn_news/year-end-report-1-january-31-december-2021/ 2023-12-13T11:00:49+00:00 https://qlinea.com/mfn_news/excellent-clinical-results-from-large-commercial-evaluation/ 2023-12-13T11:00:49+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-year-end-report-2021-on-february-17-2022/ 2023-12-13T11:00:50+00:00 https://qlinea.com/mfn_news/the-antibiotics-panel-in-astar-is-expanded-to-offer-even-broader-coverage/ 2023-12-13T11:00:50+00:00 https://qlinea.com/mfn_news/q-linea-strengthens-management-team-3/ 2023-12-13T11:00:50+00:00 https://qlinea.com/event/abgsc-investor-day-7-december-2021/ 2021-12-13T10:03:34+00:00 https://qlinea.com/mfn_news/the-first-patients-are-included-in-the-us-clinical-trial-for-astar/ 2023-12-13T11:00:50+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-september-2021/ 2023-12-13T11:00:51+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q3-2021-on-november-4-2021/ 2023-12-13T11:00:51+00:00 https://qlinea.com/mfn_news/q-linea-signs-first-commercial-evaluation-contract-for-astar/ 2023-12-13T11:00:51+00:00 https://qlinea.com/mfn_news/q-lineas-astar-launched-in-europe/ 2023-12-13T11:00:51+00:00 https://qlinea.com/mfn_news/q-linea-is-taking-the-next-step-in-the-clinical-study-for-the-us-market/ 2023-12-13T11:00:51+00:00 https://qlinea.com/testimonials/save-time-and-lives-with-improved-diagnostics/ 2021-08-16T11:51:34+00:00 https://qlinea.com/mfn_news/commercialisation-of-astar-started/ 2024-10-29T11:45:16+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q2-2021-on-july-15-2021/ 2023-12-13T11:00:52+00:00 https://qlinea.com/mfn_news/change-in-the-number-of-shares-and-votes-in-q-linea-ab-6/ 2023-12-13T11:00:52+00:00 https://qlinea.com/financialevent/interim-report-q3-2/ 2022-04-26T11:19:16+00:00 https://qlinea.com/financialevent/interim-report-q2-4/ 2022-04-25T12:37:25+00:00 https://qlinea.com/financialevent/annual-general-meeting-4/ 2022-04-25T12:35:59+00:00 https://qlinea.com/financialevent/interim-report-q1-2/ 2021-06-17T09:08:27+00:00 https://qlinea.com/financialevent/year-end-report-4/ 2021-06-17T08:57:30+00:00 https://qlinea.com/financialevent/annual-report-2021/ 2021-06-17T08:56:08+00:00 https://qlinea.com/mfn_news/q-linea-has-carried-out-a-directed-issue-of-2-2-million-shares-raising-gross-proceeds-of-sek-301-million/ 2023-12-13T11:00:52+00:00 https://qlinea.com/mfn_news/q-linea-announces-intention-to-carry-out-a-directed-share-issue-2/ 2023-12-13T11:00:53+00:00 https://qlinea.com/mfn_news/q-linea-initiates-us-510k-clinical-study-for-astar/ 2023-12-13T11:00:53+00:00 https://qlinea.com/mfn_news/commercial-evaluation-of-the-astar-system-in-europe-started/ 2023-12-13T11:00:54+00:00 https://qlinea.com/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ-3/ 2023-12-13T11:00:54+00:00 https://qlinea.com/presentations/vd-presentation-till-arsstamma-2021-05-25/ 2021-05-11T09:01:22+00:00 https://qlinea.com/presentations/redeye-theme-medtech-diagnostics-may-5th/ 2021-05-07T07:39:21+00:00 https://qlinea.com/presentations/ou-life-science-investor-conference/ 2021-05-07T07:21:38+00:00 https://qlinea.com/mfn_news/interim-report-1-january-31-march-2021/ 2024-10-29T11:45:39+00:00 https://qlinea.com/mfn_news/q-linea-achieves-ce-ivd-approval-for-astar/ 2023-12-13T11:00:54+00:00 https://qlinea.com/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-correction/ 2023-12-13T11:00:55+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q1-2021-on-may-6-2021/ 2023-12-13T11:00:55+00:00 https://qlinea.com/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-3/ 2023-12-13T11:00:55+00:00 https://qlinea.com/mfn_news/the-proposal-by-the-nomination-committee-of-q-linea-ab-publ-for-election-of-members-of-the-board-of-directors-3/ 2023-12-13T11:00:56+00:00 https://qlinea.com/mfn_news/q-linea-publish-the-annual-report-for-2020/ 2023-12-13T11:00:56+00:00 https://qlinea.com/mfn_news/q-linea-presents-positive-interim-data-from-european-trial/ 2023-12-13T11:00:57+00:00 https://qlinea.com/mfn_news/q-linea-signs-first-site-for-us-study/ 2023-12-13T11:00:57+00:00 https://qlinea.com/mfn_news/q-linea-has-received-first-order-on-astar/ 2023-12-13T11:00:57+00:00 https://qlinea.com/mfn_news/year-end-report-1-january-31-december-2020/ 2023-12-13T11:00:57+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-year-end-report-2020-on-february-18-2021/ 2023-12-13T11:00:57+00:00 https://qlinea.com/testimonials/ast-results-deeply-inform-calculated-antibiotic-treatment/ 2021-08-16T11:15:42+00:00 https://qlinea.com/testimonials/rapid-information-on-the-antimicrobial-susceptibility-profile-is-crucial/ 2021-03-24T13:44:59+00:00 https://qlinea.com/testimonials/targeted-antimicrobial-treatment-is-considered-the-only-sustainable-strategy/ 2021-03-24T13:45:25+00:00 https://qlinea.com/testimonials/the-earlier-we-can-give-targeted-treatment-the-better/ 2021-04-07T08:19:06+00:00 https://qlinea.com/testimonials/you-will-be-much-faster-in-adjusting-the-treatment/ 2022-04-07T09:59:39+00:00 https://qlinea.com/testimonials/a-huge-advantage/ 2021-03-24T13:17:30+00:00 https://qlinea.com/mfn_news/q-linea-initiates-pivotal-clinical-study-for-astar/ 2023-12-13T11:00:58+00:00 https://qlinea.com/mfn_news/jonas-jarvius-ceo-of-q-linea-presents-at-life-science-day/ 2023-12-13T11:00:58+00:00 https://qlinea.com/financialevent/interim-report-q3/ 2021-06-17T06:16:43+00:00 https://qlinea.com/financialevent/interim-report-q2-3/ 2021-06-17T06:17:11+00:00 https://qlinea.com/financialevent/annual-general-meeting-3/ 2020-11-11T12:56:42+00:00 https://qlinea.com/financialevent/interim-report-q1/ 2020-11-11T12:56:04+00:00 https://qlinea.com/financialevent/annual-report-2020/ 2020-11-11T12:54:56+00:00 https://qlinea.com/financialevent/year-end-report-3/ 2021-06-17T05:02:54+00:00 https://qlinea.com/mfn_news/q-linea-develops-portable-blood-culture-technology/ 2023-12-13T11:00:58+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-september-2020/ 2023-12-13T11:00:59+00:00 https://qlinea.com/event/redeye-life-science-day/ 2021-05-03T13:00:08+00:00 https://qlinea.com/financialevent/redeye-life-science-day/ 2020-11-10T14:47:48+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q3-2020-on-november-5-2020/ 2023-12-13T11:00:59+00:00 https://qlinea.com/mfn_news/webinar-tuesday-november-10th-equal-and-better-care-for-everyone/ 2023-12-13T11:00:59+00:00 https://qlinea.com/financialevent/redeye-diagnostics-2020/ 2020-10-26T15:54:15+00:00 https://qlinea.com/event/redeye-diagnostics-2020/ 2020-10-26T15:23:10+00:00 https://qlinea.com/mfn_news/q-linea-enters-into-an-agreement-with-hvidovre-hospital-as-a-participant-in-the-clinical-study/ 2023-12-13T11:01:00+00:00 https://qlinea.com/mfn_news/q-linea-installs-the-first-astar-system-at-uppsala-university-hospital/ 2023-12-13T11:01:00+00:00 https://qlinea.com/event/pareto-securities-11th-annual-healthcare-conference/ 2020-10-29T14:53:25+00:00 https://qlinea.com/financialevent/pareto-securities-11th-annual-healthcare-conference/ 2020-08-31T13:47:48+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-june-2020/ 2023-12-13T11:01:00+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q2-2020-on-july-16-2020/ 2023-12-13T11:01:00+00:00 https://qlinea.com/mfn_news/change-in-the-number-of-shares-and-votes-in-q-linea-ab/ 2023-12-13T11:01:01+00:00 https://qlinea.com/financialevent/annual-general-meeting-2/ 2020-06-11T09:14:42+00:00 https://qlinea.com/financialevent/interim-report-quarter-1-2/ 2020-06-11T09:13:46+00:00 https://qlinea.com/financialevent/annual-report-2019/ 2020-06-11T09:13:11+00:00 https://qlinea.com/financialevent/year-end-report-2/ 2020-06-11T09:09:12+00:00 https://qlinea.com/financialevent/interim-report-quarter-3/ 2020-06-11T09:05:50+00:00 https://qlinea.com/financialevent/interim-report-quarter-2/ 2020-06-11T09:02:27+00:00 https://qlinea.com/financialevent/annual-general-meeting/ 2020-06-11T08:56:47+00:00 https://qlinea.com/financialevent/interim-report-quarter-1/ 2020-06-11T08:58:28+00:00 https://qlinea.com/financialevent/year-end-report/ 2020-06-11T08:48:59+00:00 https://qlinea.com/event/webinar-june-5th-2020/ 2020-10-06T10:08:26+00:00 https://qlinea.com/financialevent/interim-report-q2-2/ 2020-06-05T08:43:46+00:00 https://qlinea.com/financialevent/interim-report-q2/ 2020-06-05T08:43:22+00:00 https://qlinea.com/mfn_news/q-linea-has-carried-out-a-directed-issue-of-4-million-shares-raising-proceeds-of-sek-270-million6/ 2023-12-13T11:01:01+00:00 https://qlinea.com/mfn_news/q-linea-announces-intention-to-carry-out-a-directed-share-issue/ 2023-12-13T11:01:01+00:00 https://qlinea.com/event/redeye-growth-day-2020-06-02/ 2020-07-22T08:31:24+00:00 https://qlinea.com/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ/ 2023-12-13T11:01:02+00:00 https://qlinea.com/mfn_news/webinar-friday-june-5th-how-can-we-improve-infection-diagnostics-with-astar/ 2023-12-13T11:01:02+00:00 https://qlinea.com/mfn_news/q-linea-announces-positive-results-from-prospective-study-with-astar/ 2023-12-13T11:01:03+00:00 https://qlinea.com/mfn_news/interim-report-1-january-31-march-2020/ 2023-12-13T11:01:03+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q1-2020-on-may-7-2020/ 2023-12-13T11:01:03+00:00 https://qlinea.com/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ/ 2023-12-13T11:01:03+00:00 https://qlinea.com/mfn_news/the-proposal-by-the-nomination-committee-of-q-linea-ab-publ-for-election-of-members-of-the-board-of-directors/ 2023-12-13T11:01:03+00:00 https://qlinea.com/mfn_news/q-linea-publish-the-annual-report-for-2019/ 2023-12-13T11:01:04+00:00 https://qlinea.com/mfn_news/q-linea-has-solved-the-component-problem/ 2023-12-13T11:01:04+00:00 https://qlinea.com/presentations/jonas-jarvius-ceo-president-presents-at-redeye-march-12-2020/ 2020-03-18T08:53:50+00:00 https://qlinea.com/presentations/interview-with-ceo-jonas-jarvius-2018-12-07/ 2020-02-17T08:06:26+00:00 https://qlinea.com/presentations/interview-with-ceo-jonas-jarvius-2020-02-13/ 2020-06-10T03:22:23+00:00 https://qlinea.com/mfn_news/year-end-report-1-january-31-december-2019/ 2023-12-13T11:01:04+00:00 https://qlinea.com/mfn_news/q-linea-signs-global-partnership-with-thermo-fisher-scientific-for-commercialization-of-astar/ 2023-12-13T11:01:05+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-year-end-report-q4-2019-on-february-13-2020/ 2023-12-13T11:01:05+00:00 https://qlinea.com/event/kempen-life-sciences-conference/ 2020-02-04T08:02:32+00:00 https://qlinea.com/presentations/stockholm-corporate-finance-12th-life-science-seminar/ 2020-06-05T10:15:34+00:00 https://qlinea.com/mfn_news/change-in-the-number-of-shares-and-votes-in-q-linea-ab-2/ 2023-12-13T11:01:05+00:00 https://qlinea.com/event/life-science-investorkonference-q1-2020/ 2020-06-10T03:22:24+00:00 https://qlinea.com/event/annual-general-meeting-2020/ 2020-01-09T10:27:10+00:00 https://qlinea.com/event/carnegie-nordic-healthcare-seminar-stockholm/ 2020-01-09T10:26:42+00:00 https://qlinea.com/event/year-end-report-january-to-december-2019/ 2020-01-09T10:05:52+00:00 https://qlinea.com/event/annual-report-2019/ 2020-01-09T09:57:26+00:00 https://qlinea.com/presentations/in-swedish-interview-with-ceo-jonas-jarvius-redeye-after-work-november-8th-2019/ 2019-11-07T09:28:40+00:00 https://qlinea.com/presentations/jonas-jarvius-ceo-presentation-redeye-after-work-november-8th-2019/ 2019-11-07T09:25:56+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-september-2019/ 2023-12-13T11:01:06+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q3-2019-on-november-7-2019/ 2023-12-13T11:01:06+00:00 https://qlinea.com/mfn_news/q-linea-receives-positive-response-from-the-fda-for-the-design-of-the-companys-planned-clinical-study-in-the-usa/ 2023-12-13T11:01:06+00:00 https://qlinea.com/mfn_news/q-linea-postpones-start-of-the-clinical-trials/ 2023-12-13T11:01:06+00:00 https://qlinea.com/mfn_news/q-linea-strengthens-management-team/ 2023-12-13T11:01:07+00:00 https://qlinea.com/mfn_news/change-in-the-number-of-shares-and-votes-in-q-linea-ab-3/ 2023-12-13T11:01:07+00:00 https://qlinea.com/mfn_news/interim-report-1-january-30-june-2019/ 2023-12-13T11:01:07+00:00 https://qlinea.com/mfn_news/q-linea-strengthens-management-team-2/ 2023-12-13T11:01:07+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q2-2019-on-july-18-2019/ 2023-12-13T11:01:07+00:00 https://qlinea.com/mfn_news/issue-and-repurchase-of-class-c-shares-for-incentive-program/ 2023-12-13T11:01:08+00:00 https://qlinea.com/mfn_news/bulletin-from-annual-general-meeting-in-q-linea-ab-publ-2/ 2023-12-13T11:01:08+00:00 https://qlinea.com/mfn_news/interim-report-1-january-31-march-2019/ 2023-12-13T11:01:08+00:00 https://qlinea.com/mfn_news/invitation-to-presentation-of-q-lineas-interim-report-q1-2019-on-may-3-2019/ 2023-12-13T11:01:08+00:00 https://qlinea.com/mfn_news/notice-of-annual-general-meeting-in-q-linea-ab-publ-2/ 2023-12-13T11:01:09+00:00 https://qlinea.com/mfn_news/q-linea-publish-the-annual-report-for-2018/ 2023-12-13T11:01:09+00:00 https://qlinea.com/mfn_news/q-lineas-astar-a-success-on-eccmid/ 2023-12-13T11:01:09+00:00 https://qlinea.com/mfn_news/the-proposal-by-the-nomination-committee-of-q-linea-ab-publ-for-election-of-members-of-the-board-of-directors-2/ 2023-12-13T11:01:09+00:00 https://qlinea.com/mfn_news/change-in-the-number-of-shares-and-votes-in-q-linea-ab-4/ 2023-12-13T11:01:10+00:00 https://qlinea.com/mfn_news/q-linea-can-reach-its-main-market-faster-than-planned/ 2023-12-13T11:01:10+00:00 https://qlinea.com/mfn_news/year-end-report-1-january-31-december-2018/ 2023-12-13T11:01:11+00:00 https://qlinea.com/mfn_news/stabilization-notice-and-end-of-the-stabilization-period/ 2023-12-13T11:01:11+00:00 https://qlinea.com/mfn_news/change-in-the-number-of-shares-and-votes-in-q-linea-ab-5/ 2023-12-13T11:01:11+00:00 https://qlinea.com/mfn_news/stabilization-notice/ 2023-12-13T11:01:11+00:00 https://qlinea.com/mfn_news/trading-in-q-lineas-share-commences-tomorrow-on-nasdaq-stockholm/ 2023-12-13T11:01:11+00:00 https://qlinea.com/mfn_news/q-linea-publishes-prospectus-for-initial-public-offering-on-nasdaq/ 2023-12-13T11:01:12+00:00